Merck KGaA, WuXi AppTec Co., Ltd., Charles River Laboratories International, Inc., Texcell SA, Vironova AB, and Sartorius AG, among others, are leading players in the global viral clearance market. Other significant players include Syngene International Limited, Creative Biogene, and Eurofins Scientific, among others.
The global viral clearance market would likely grow at a CAGR of 9.6% during 2022-2027. Viral contamination poses a common but significant threat to human and animal-derived biopharmaceuticals. Such contamination may affect any phase of a bioproduction process, and biomanufacturers must carry out viral testing studies and include viral clearance methods into their procedures. Viral clearance refers to removal of viral contamination with the help of specialized membranes (generally proteins) or chromatography. To ensure that therapeutic drugs drawn from particular sources are free of viral contamination, protein solutions go through viral clearance to remove or inactivate viral material. Asia Pacific, North America and Europe are likely to be key markets.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Merck KGaA is a leading science and technology company. In Healthcare, the company seeks to discover unique treatments to challenging diseases, such as cancer and multiple sclerosis. In electronics, the company develops science to change the way information is accessed, stored, processed, and displayed. Specialties include Chemicals, Pharmaceuticals, Science and Technology.
WuXi AppTec Co., Ltd. has operations across Europe, Asia, and North America. The company offers an extensive range of R&D and manufacturing services enabling the discovery and delivery of pathbreaking treatment systems. Specialties include Bioanalytical, Drug Discovery, Clinical and Regulatory, Lab Testing, Genomics, API Development and Manufacturing, Biological Reagents, Drug Development, Medical Device, Biologics, Toxicology, Chemistry, Cell and Gene Therapy, and Contract Research Organization.
Charles River Laboratories International, Inc. offers essential services and products to help biotechnology and pharmaceutical companies, academic institutions and government agencies across the world expedite their research and drug development endeavours. Specialties include Preclinical Services, Research Models & Services, Biologics Testing Solutions, Discovery Research Services, Endotoxin Testing, Microbial Identification, Early Discovery, LAL, Safety Testing, and Agrochemical.
|Headquarters:||Évry, Évry-Courcouronnes, France|
Texcell SA is a leading player in biotechnology and pharmaceutical domains. Through a distinct mix of expertise in Virology and Immunology, the company provides significant support to product development from proof of concept to clinical studies and GMP manufacturing. The company’s modern facilities are situated in USA, Germany and France, and it uses recent technologies to efficiently carry out a broad range of assays. Specialties include Bioanalysis, Viral Safety, GMP, GLP, Medical Device, GCLP, Viral Clearance, Biosafety Testing, Immunoprofiling, Safety Testing, and Clinical trials
Vironova AB is a major player in the life sciences domain engaged in the development of new therapies. The company focuses on innovation and technology; it offers quick and economical electron microscopy services enabled by the company’s own hardware and software. Specialties include Transmission electron microscopy, Nano-characterization, Virus safety, Viral clearance, software, gene therapy, electron microscopy, biotechnology, bioprocessing, vaccines, drug delivery, biopharmaceutical development, pharmaceutical industry, and life science.
Sartorius AG is a quickly growing international life science company that covers the segments of Bioprocess Solutions and Lab Products & Services. The company has 14,000 employees across more than 60 production and sales locations across the globe.
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.